These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5458217)

  • 1. Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS; Hierholzer JC
    Am J Epidemiol; 1970 Oct; 92(4):248-56. PubMed ID: 5458217
    [No Abstract]   [Full Text] [Related]  

  • 2. A clinical and serologic comparison of standard and purified bivalent inactivated influenza vaccines.
    Finklea JF; Sandifer SH; Peck FB; Manos JP
    J Infect Dis; 1969 Dec; 120(6):708-12. PubMed ID: 4911903
    [No Abstract]   [Full Text] [Related]  

  • 3. Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Postgrad Med J; 1973 Mar; 49(569):152-8. PubMed ID: 4802501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenicity of influenza vaccine from bovine cell cultures.
    Leiderman E; Mogabgab WJ
    Appl Microbiol; 1969 Oct; 18(4):596-600. PubMed ID: 4905036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 10. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.
    Knight V; Couch RB; Douglas RG; Tauraso NM
    Bull World Health Organ; 1971; 45(6):767-71. PubMed ID: 5317012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A field evaluation of inactivated, zonal-centrifuged influenza vaccines in children in Chapel Hill, North Carolina, 1968-69.
    Glezen WP; Loda FA; Denny FW
    Bull World Health Organ; 1969; 41(3):566-9. PubMed ID: 5309478
    [No Abstract]   [Full Text] [Related]  

  • 13. Influenza immunization. A new vaccine.
    Cromwell HA; Brandon FB; McLean IW; Sadusk JF
    JAMA; 1969 Nov; 210(8):1438-42. PubMed ID: 5394875
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization of children with chronic lung disease with inactivated bivalent influenza vaccine.
    Jamison RM; Hilman BC; Kelly DA
    South Med J; 1972 Jul; 65(7):823-9. PubMed ID: 5038174
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Bull World Health Organ; 1969; 41(3):525-30. PubMed ID: 5309467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related response to 1000 CCA unit zonally purified, inactivated influenza vaccines in volunteers in the U.S.A.
    Marine WM; Thomas JE
    Postgrad Med J; 1973 Mar; 49(569):164-8. PubMed ID: 4802389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-inducing effects of aqueous and depot influenza vaccines in the elderly.
    Lamb GA; Feldman HA; Flescher R
    Am J Med Sci; 1967 Oct; 254(4):513-27. PubMed ID: 6052847
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on inactivated influenza vaccines. I. The effect of dosage on antibody response and protection against homotypic and heterotypic influenza virus challenge in mice.
    Kaye HS; Dowdle WR; McQueen JL
    Am J Epidemiol; 1969 Aug; 90(2):162-9. PubMed ID: 5804363
    [No Abstract]   [Full Text] [Related]  

  • 20. Human influenza: aspects of the immune response to vaccination.
    Ann Intern Med; 1969 Aug; 71(2):369-98. PubMed ID: 4184389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.